Single Wire Serial Interface
    61.
    发明申请
    Single Wire Serial Interface 有权
    单线串行接口

    公开(公告)号:US20110202787A1

    公开(公告)日:2011-08-18

    申请号:US13028139

    申请日:2011-02-15

    IPC分类号: G06F1/04

    摘要: A single wire serial interface for power ICs and other devices is provided. To use the interface, a device is configured to include an EN/SET input pin. A counter within the device counts clock pulses sent to the EN/SET input pin. The output of the counter is passed to a ROM or other decoder circuit. The ROM selects an operational state for the device that corresponds to the value of the counter. In this way, control states may be selected for the device by sending corresponding clock pulses to the EN/SET pin. Holding the EN/SET pin high causes the device to maintain its operational state. Holding the EN/SET pin low for a predetermined timeout period resets the counter and causes the device to adopt a predetermined configuration (such as off) until new clock pulses are received at the EN/SET pin.

    摘要翻译: 提供了用于电源IC和其他设备的单线串行接口。 要使用该接口,设备配置为包含一个EN / SET输入引脚。 器件内的计数器计数发送到EN / SET输入引脚的时钟脉冲。 计数器的输出传递给ROM或其他解码器电路。 ROM选择与计数器的值相对应的设备的操作状态。 以这种方式,可以通过向EN / SET引脚发送相应的时钟脉冲来为器件选择控制状态。 将EN / SET引脚保持为高电平使器件保持其工作状态。 将EN / SET引脚保持低电平达预定的超时周期,复位计数器,并使器件采取预定的配置(如关闭),直到在EN / SET引脚接收到新的时钟脉冲。

    OXIDIZED LDL SPECIFIC ANTIBODY-FUSION AND CONJUGATED PROTEINS
    62.
    发明申请
    OXIDIZED LDL SPECIFIC ANTIBODY-FUSION AND CONJUGATED PROTEINS 审中-公开
    氧化低密度脂蛋白特异性抗体融合和结合蛋白

    公开(公告)号:US20110182851A1

    公开(公告)日:2011-07-28

    申请号:US13003648

    申请日:2009-07-13

    申请人: Jan Nilsson

    发明人: Jan Nilsson

    摘要: The present invention relates to complete oxidized LDL specific IgG fused or conjugated with at least one of the proteins of the group IL-10, TIMPs, and TGFβs to be used in a medicine, the use thereof for treatment of atherosclerosis and prevention of clinical events in patients with atherosclerosis, pharmaceutical compositions containing the same, as well as method for treatment of atherosclerosis and prevention of clinical events in patients with atherosclerosis.

    摘要翻译: 本发明涉及与药物中使用的IL-10,TIMP和TGFβ组合中的至少一种蛋白质融合或缀合的完全氧化的LDL特异性IgG,其用于治疗动脉粥样硬化和预防 动脉粥样硬化患者的临床事件,包含其的药物组合物,以及用于治疗动脉粥样硬化和预防动脉粥样硬化患者临床事件的方法。

    METHOD AND ARRANGEMENT FOR TRANSFERRING PACKAGING CONTAINERS FROM A FIRST UNIT TO A SECOND UNIT
    63.
    发明申请
    METHOD AND ARRANGEMENT FOR TRANSFERRING PACKAGING CONTAINERS FROM A FIRST UNIT TO A SECOND UNIT 有权
    将包装容器从第一单元转移到第二单元的方法和装置

    公开(公告)号:US20110150619A1

    公开(公告)日:2011-06-23

    申请号:US12988795

    申请日:2009-04-23

    申请人: Jan Nilsson

    发明人: Jan Nilsson

    IPC分类号: B65G47/52

    摘要: The invention relates to a method for synchronizing, and a transfer device for synchronizing, a movement pattern between two units in a packaging line, wherein one unit is intermittently operated and the second unit is continuously operated. The invention is particularly intended for a transfer device between an intermittently operated filler unit and a continuously operated cartoning machine. The transfer device is provided with a frame (13) arranged to support tube pickers-/placers (28) and is arranged to perform a simultaneous pivoting movement about a first and a second shaft (16, 31), and for rotation about a third shaft (48) at right angles to the second shaft (31). The frame is further provided with means for adjusting the spacing between the tubes and means for compensating for differences in vertical position during the rotating movement in the case where the containers picked from the part circular conveyor of the filling unit.

    摘要翻译: 本发明涉及一种用于同步的方法和用于使包装线中的两个单元之间的运动模式同步的转移装置,其中一个单元被间歇地操作,并且第二单元被连续操作。 本发明特别适用于间歇操作的填充单元和连续操作的装盒机之间的转移装置。 传送装置设置有框架(13),其布置成支撑管拾取器/放置器(28),并被布置成执行围绕第一和第二轴(16,31)的同时枢转运动,并且围绕第三和第三 轴(48)与第二轴(31)成直角。 框架还设置有用于调节管之间的间距的装置和用于在从填充单元的部分圆形输送机拾取的容器的情况下补偿旋转运动期间垂直位置的差异的装置。

    USE OF MODIFIED EXTRACELLULAR MATRIX PROTEINS IN DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS
    64.
    发明申请
    USE OF MODIFIED EXTRACELLULAR MATRIX PROTEINS IN DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS 审中-公开
    改良的细胞外基质蛋白在诊断和治疗角质层病中的应用

    公开(公告)号:US20100279325A1

    公开(公告)日:2010-11-04

    申请号:US12814137

    申请日:2010-06-11

    申请人: Jan Nilsson

    发明人: Jan Nilsson

    IPC分类号: G01N33/53 C07K16/00

    摘要: The present invention relates to the use of fibronectin, tenascin, collagens type I, III, VI and/or VIII modified by aldehyde or by glycosylation in ELISA for detection of antibodies in plasma and serum to diagnose atherosclerosis as well as the use of induction of tolerance and active as well as passive immunization against glycosylated or aldehydemodified fibronectin, tenascin, collagen type I, III, VI and/or VIII for prevention and treatment of atherosclerosis.

    摘要翻译: 本发明涉及纤连蛋白,腱生蛋白,通过醛修饰的I型,III型,VI型和/或VIII型胶原的用途,或通过在ELISA中的糖基化检测血浆和血清中的抗体来诊断动脉粥样硬化以及使用诱导 耐受性和活性以及针对糖基化或醛化纤维连接蛋白,腱生蛋白,I型胶原,III,VI和/或VIII型的被动免疫,用于预防和治疗动脉粥样硬化。

    PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS
    65.
    发明申请
    PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS 有权
    基于肽的免疫治疗治疗甲状腺功能亢进

    公开(公告)号:US20100004430A1

    公开(公告)日:2010-01-07

    申请号:US12394827

    申请日:2009-02-27

    IPC分类号: C07K16/18

    摘要: The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of said antibodies.

    摘要翻译: 本发明涉及使用一种或多种所述抗体针对缺血性心血管疾病免疫或治疗哺乳动物(包括人)的载脂蛋白B的片段,特别是其定义的肽,针对该抗体产生抗体。

    Peptide-based passive immunization therapy for treatment of atherosclerosis
    66.
    发明授权
    Peptide-based passive immunization therapy for treatment of atherosclerosis 失效
    基于肽的被动免疫治疗动脉粥样硬化

    公开(公告)号:US07601353B2

    公开(公告)日:2009-10-13

    申请号:US11323123

    申请日:2005-12-30

    IPC分类号: A61K39/395 C07K16/00

    摘要: The present invention relates to passive immunization for treating or preventing atherosclerosis using an isolated human antibody directed towards at least one oxidized fragment of apolipoprotein B in the manufacture of a pharmaceutical composition for therapeutical or prophylactical treatment of atherosclerosis by means of passive immunization, as well as method for preparing such antibodies, and a method for treating a mammal, preferably a human using such an antibody to provide for passive immunization.

    摘要翻译: 本发明涉及用于治疗或预防动脉粥样硬化的被动免疫,其使用针对至少一种载脂蛋白B的氧化片段的分离的人抗体制造用于通过被动免疫治疗或预防性治疗动脉粥样硬化的药物组合物,以及 制备这种抗体的方法,以及使用这种抗体治疗哺乳动物,优选人的方法以提供被动免疫。

    Surveillance system for real-time threat monitoring
    68.
    发明申请
    Surveillance system for real-time threat monitoring 审中-公开
    监控系统进行实时威胁监控

    公开(公告)号:US20090167511A1

    公开(公告)日:2009-07-02

    申请号:US11630469

    申请日:2005-06-14

    CPC分类号: G08B25/08 G08B21/12 G08B25/10

    摘要: Surveillance system for automatic detection and presentation of threat indications, the system comprising several threat indication detectors and at least one central unit adapted for communication with said threat indication detectors and for presentation of threat images. Threat information signals are transferred automatically from the threat indication detectors to the central unit, and each threat indication detector can be located both immobile, semi-mobile of mobile.

    摘要翻译: 用于自动检测和呈现威胁指示的监视系统,该系统包括若干威胁指示检测器和至少一个适于与所述威胁指示检测器通信并用于呈现威胁图像的中央单元。 威胁信息信号自动从威胁指示检测器传输到中央单元,并且每个威胁指示检测器都可以位于移动的移动,半移动的移动。